Polymorphous adenocarcinoma is characterized by the PRKD1-E710D fusion gene, resulting from the rearrangement of the PRKD1 gene, yet it does not significantly affect tumor prognosis. This evidence concerns the gene PRKD1 and adenocarcinoma.